Kissei Pharmaceutical Co., Ltd. (4547.T)
JPY 3620.0
(-1.23%)
JPY 3620.0
(-1.23%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 33.32 Billion JPY | -9.24% |
| 2022 | 33.5 Billion JPY | 2.64% |
| 2021 | 32.64 Billion JPY | 4.56% |
| 2020 | 31.21 Billion JPY | -5.54% |
| 2019 | 33.04 Billion JPY | -16.04% |
| 2018 | 39.36 Billion JPY | 2.96% |
| 2017 | 38.23 Billion JPY | 0.24% |
| 2016 | 38.14 Billion JPY | 1.87% |
| 2015 | 37.43 Billion JPY | -0.72% |
| 2014 | 37.71 Billion JPY | 8.0% |
| 2013 | 34.91 Billion JPY | 3.96% |
| 2012 | 33.58 Billion JPY | -2.1% |
| 2011 | 34.3 Billion JPY | -3.18% |
| 2010 | 35.43 Billion JPY | 4.72% |
| 2009 | 33.83 Billion JPY | -1.71% |
| 2008 | 34.42 Billion JPY | 0.03% |
| 2007 | 34.41 Billion JPY | 2.56% |
| 2006 | 33.55 Billion JPY | -0.88% |
| 2005 | 33.84 Billion JPY | 6.14% |
| 2004 | 31.88 Billion JPY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | -10.89 Billion JPY | 81.31% |
| 2024 Q1 | 6 Billion JPY | -32.68% |
| 2023 Q2 | 8.33 Billion JPY | 4.86% |
| 2023 Q1 | 7.94 Billion JPY | -7.69% |
| 2023 FY | 30.4 Billion JPY | -9.24% |
| 2023 Q3 | 8.11 Billion JPY | -2.63% |
| 2023 Q4 | 8.92 Billion JPY | 9.96% |
| 2022 Q1 | 8.01 Billion JPY | -2.66% |
| 2022 FY | 33.5 Billion JPY | 2.64% |
| 2022 Q2 | 8.79 Billion JPY | 9.63% |
| 2022 Q3 | 8.08 Billion JPY | -8.07% |
| 2022 Q4 | 8.61 Billion JPY | 6.55% |
| 2021 Q2 | 7.62 Billion JPY | 0.62% |
| 2021 Q3 | 9.2 Billion JPY | 20.85% |
| 2021 FY | 32.64 Billion JPY | 4.56% |
| 2021 Q4 | 8.23 Billion JPY | -10.54% |
| 2021 Q1 | 7.57 Billion JPY | -14.81% |
| 2020 Q1 | 6.62 Billion JPY | -17.06% |
| 2020 Q3 | 8.27 Billion JPY | 11.45% |
| 2020 FY | 31.21 Billion JPY | -5.54% |
| 2020 Q4 | 8.89 Billion JPY | 7.42% |
| 2020 Q2 | 7.42 Billion JPY | 12.09% |
| 2019 Q1 | 7.98 Billion JPY | -13.64% |
| 2019 Q4 | 7.98 Billion JPY | -8.14% |
| 2019 Q3 | 8.69 Billion JPY | 3.77% |
| 2019 FY | 33.04 Billion JPY | -16.04% |
| 2019 Q2 | 8.38 Billion JPY | 4.96% |
| 2018 FY | 39.36 Billion JPY | 2.96% |
| 2018 Q3 | 12.21 Billion JPY | 29.48% |
| 2018 Q4 | 9.24 Billion JPY | -24.3% |
| 2018 Q1 | 8.47 Billion JPY | -8.41% |
| 2018 Q2 | 9.43 Billion JPY | 11.32% |
| 2017 FY | 38.23 Billion JPY | 0.24% |
| 2017 Q4 | 9.25 Billion JPY | 4.65% |
| 2017 Q3 | 8.84 Billion JPY | -5.54% |
| 2017 Q2 | 9.35 Billion JPY | -13.22% |
| 2017 Q1 | 10.78 Billion JPY | 8.28% |
| 2016 FY | 38.14 Billion JPY | 1.87% |
| 2016 Q1 | 9.01 Billion JPY | -24.42% |
| 2016 Q2 | 9.76 Billion JPY | 8.31% |
| 2016 Q3 | 9.41 Billion JPY | -3.58% |
| 2016 Q4 | 9.95 Billion JPY | 5.81% |
| 2015 Q1 | 9.08 Billion JPY | -21.45% |
| 2015 Q3 | 7.73 Billion JPY | -11.13% |
| 2015 Q2 | 8.7 Billion JPY | -4.21% |
| 2015 Q4 | 11.92 Billion JPY | 54.17% |
| 2015 FY | 37.43 Billion JPY | -0.72% |
| 2014 Q1 | 8.09 Billion JPY | -17.19% |
| 2014 FY | 37.71 Billion JPY | 8.0% |
| 2014 Q4 | 11.56 Billion JPY | 36.24% |
| 2014 Q3 | 8.48 Billion JPY | -11.25% |
| 2014 Q2 | 9.56 Billion JPY | 18.16% |
| 2013 Q4 | 9.77 Billion JPY | 16.34% |
| 2013 FY | 34.91 Billion JPY | 3.96% |
| 2013 Q1 | 7.81 Billion JPY | -14.46% |
| 2013 Q2 | 8.92 Billion JPY | 14.17% |
| 2013 Q3 | 8.4 Billion JPY | -5.87% |
| 2012 Q3 | 7.93 Billion JPY | -8.78% |
| 2012 FY | 33.58 Billion JPY | -2.1% |
| 2012 Q2 | 8.7 Billion JPY | 11.41% |
| 2012 Q1 | 7.81 Billion JPY | -12.41% |
| 2012 Q4 | 9.13 Billion JPY | 15.13% |
| 2011 Q1 | 8.35 Billion JPY | -4.04% |
| 2011 FY | 34.3 Billion JPY | -3.18% |
| 2011 Q2 | 8.71 Billion JPY | 4.35% |
| 2011 Q3 | 8.31 Billion JPY | -4.55% |
| 2011 Q4 | 8.91 Billion JPY | 7.19% |
| 2010 Q4 | 8.7 Billion JPY | 5.78% |
| 2010 Q1 | 9.01 Billion JPY | -0.3% |
| 2010 FY | 35.43 Billion JPY | 4.72% |
| 2010 Q2 | 9.48 Billion JPY | 5.21% |
| 2010 Q3 | 8.22 Billion JPY | -13.23% |
| 2009 Q2 | 8.18 Billion JPY | -3.76% |
| 2009 Q4 | 9.04 Billion JPY | 11.53% |
| 2009 Q3 | 8.1 Billion JPY | -0.94% |
| 2009 Q1 | 8.5 Billion JPY | -4.15% |
| 2009 FY | 33.83 Billion JPY | -1.71% |
| 2008 Q2 | 8.9 Billion JPY | 0.0% |
| 2008 FY | 34.42 Billion JPY | 0.03% |
| 2008 Q3 | 8.62 Billion JPY | -3.11% |
| 2008 Q4 | 8.87 Billion JPY | 2.8% |
| 2007 FY | 34.41 Billion JPY | 2.56% |
| 2006 FY | 33.55 Billion JPY | -0.88% |
| 2005 FY | 33.84 Billion JPY | 6.14% |
| 2004 FY | 31.88 Billion JPY | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 43.63 Billion JPY | 23.637% |
| Takeda Pharmaceutical Company Limited | 2618.18 Billion JPY | 98.727% |
| Sumitomo Pharma Co., Ltd. | 542.17 Billion JPY | 93.854% |
| Shionogi & Co., Ltd. | 197.62 Billion JPY | 83.138% |
| Wakamoto Pharmaceutical Co.,Ltd. | 3.73 Billion JPY | -791.884% |
| Nippon Shinyaku Co., Ltd. | 65.63 Billion JPY | 49.225% |
| Kaken Pharmaceutical Co., Ltd. | 29.02 Billion JPY | -14.807% |
| Eisai Co., Ltd. | 533.01 Billion JPY | 93.748% |
| Morishita Jintan Co., Ltd. | 5.28 Billion JPY | -530.897% |
| Hisamitsu Pharmaceutical Co., Inc. | 65.8 Billion JPY | 49.359% |
| Mochida Pharmaceutical Co., Ltd. | 46.26 Billion JPY | 27.975% |
| Fuso Pharmaceutical Industries,Ltd. | 11.55 Billion JPY | -188.445% |
| Nippon Chemiphar Co., Ltd. | 8.23 Billion JPY | -304.81% |
| Tsumura & Co. | 48.8 Billion JPY | 31.713% |
| Torii Pharmaceutical Co., Ltd. | 19.53 Billion JPY | -70.569% |
| Towa Pharmaceutical Co., Ltd. | 63.73 Billion JPY | 47.716% |
| Fuji Pharma Co., Ltd. | 12.65 Billion JPY | -163.285% |
| Zeria Pharmaceutical Co., Ltd. | 40.46 Billion JPY | 17.647% |
| KYORIN Holdings, Inc. | 45.39 Billion JPY | 26.591% |
| Taiko Pharmaceutical Co.,Ltd. | 4.15 Billion JPY | -701.636% |
| Daito Pharmaceutical Co.,Ltd. | 5.94 Billion JPY | -460.538% |
| SymBio Pharmaceuticals Limited | 5.22 Billion JPY | -538.063% |
| MedRx Co., Ltd | 959 Million JPY | -3374.87% |
| Mizuho Medy Co.,Ltd. | 2.87 Billion JPY | -1059.608% |
| Solasia Pharma K.K. | 1.47 Billion JPY | -2157.724% |
| Modalis Therapeutics Corporation | 2.37 Billion JPY | -1305.682% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 24.16 Billion JPY | -37.902% |
| Sawai Group Holdings Co., Ltd. | 35.43 Billion JPY | 5.952% |
| Cyfuse Biomedical K.K. | 735.18 Million JPY | -4432.761% |
| Toho Holdings Co., Ltd. | 99.81 Billion JPY | 66.615% |
| Koa Shoji Holdings Co.,Ltd. | 2.25 Billion JPY | -1376.285% |